ENSIKLOPEDIA Cari Tekan Enter untuk memulai pencarian cepat. Kembali ke Ensiklopedia Arsip Wikipedia Indonesia Iopromide IopromideChemical compound Pharmaceutical compoundIopromideClinical dataTrade namesUltravistAHFS/Drugs.comMicromedex Detailed Consumer InformationPregnancycategory AU: B2 Routes ofadministrationIntravascularATC codeV08AB05 (WHO) Legal statusLegal status US: ℞-only Pharmacokinetic dataProtein binding~1%MetabolismNoneElimination half-life2 hoursExcretionKidneysIdentifiers IUPAC name 1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-1-N-methylbenzene-1,3-dicarboxamide CAS Number73334-07-3 NPubChem CID3736DrugBankDB09156 YChemSpider3605 NUNII712BAC33MZKEGGD01893 YChEBICHEBI:63578 NChEMBLChEMBL1725 NCompTox Dashboard (EPA)DTXSID0023163 ECHA InfoCard100.070.330 Chemical and physical dataFormulaC18H24I3N3O8Molar mass791.116 g·mol−13D model (JSmol)Interactive image SMILES CN(CC(CO)O)C(=O)c1c(c(c(c(c1I)NC(=O)COC)I)C(=O)NCC(CO)O)I InChI InChI=1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29) NKey:DGAIEPBNLOQYER-UHFFFAOYSA-N N NY (what is this?) (verify) Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.[1] It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT)[1] and CT pulmonary angiograms (CTPAs). Medical uses The radiocontrast agent is given intravenously in computed tomography (CT) scans, angiography and excretory urography.[2] Contraindications Iopromide use is contraindicated in myelography, cerebral ventriculography and cisternography procedures. It is also contraindicated in those with hyperthyroidism, or with known allergy to the drug.[3] Iopromide is also contraindicated in children with prolonged fasting, fluid restriction, on laxative, or dehydration as it can cause renal failure.[3] References 1 2 Haberfeld H, ed. (2020). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. Ultravist 300 mg J/ml-Infusionsflaschen. ↑ "Prescribing information - Ultravist" (PDF). Bayer Healthcare pharmaceuticals. Archived from the original (PDF) on 10 April 2021. 1 2 "PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ULTRAVIST® Iopromide Injection" (PDF). Bayer Healthcare Pharmaceuticals. Archived from the original (PDF) on 27 October 2021. Retrieved 16 April 2024. External links Bayer US Ultravist Website vteContrast media (V08)X-ray and CTIodinated,Water solubleNephrotropic,high osmolar Diatrizoic acid# Metrizoic acid Iodamide Iotalamic acid Ioxitalamic acid Ioglicic acid Acetrizoic acid Iocarmic acid Methiodal Diodone Nephrotropic,low osmolar Metrizamide Iohexol# Ioxaglic acid Iopamidol Iopromide Iotrolan Ioversol Iopentol Iodixanol Iomeprol Iobitridol Ioxilan Hepatotropic Iodoxamic acid Iotroxic acid# Ioglycamic acid Adipiodone Iobenzamic acid Iopanoic acid Iocetamic acid Sodium iopodate Tyropanoic acid Calcium iopodate Iodinated,Water insoluble Ethiodized oil (= Ethyl esters of iodised fatty acids, lipiodol) Iopydol Propyliodone Iofendylate‡ Non-iodinated Barium sulfate# MRIParamagnetic Gadolinium-based: Gadobenic acid Gadobutrol Gadodiamide Gadofosveset Gadolinium Gadopentetic acid Gadopiclenol Gadoteric acid Gadoteridol Gadoversetamide Gadoxetic acid Other: Ferric ammonium citrate Mangafodipir‡ Superparamagnetic Ferumoxsil Ferristene Iron oxide, nanoparticles Other Perflubron Ultrasound Microspheres of human albumin Microparticles of galactose Perflenapent Microspheres of phospholipids Sulfur hexafluoride #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III This pharmacology-related article is a stub. You can help Wikipedia by adding missing information.vte
